samedan logo
 
 
spacer
home > pmps > summer 2019 > a strong partner from drug discovery to delivery
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Strong Partner from Drug Discovery to Delivery

R&D efforts are of immense importance for the healthcare industry and its successful contribution to human health. However, as the requirements for, and the complexity of, medical solutions are rising, manufacturers face multiple challenges when it comes to the development of new drug solutions. A decisive factor within drug development is testing under real conditions. To ease a high-quality test scenario during drug development, Datwyler launched its Starter Pack solution with SCHOTT.

Drug development is no easy task: from drug discovery through to approval, developing a new medicine takes, on average, 10-15 years and costs around $2.6 billion. Less than 12% of the candidate medicines that make it into Phase I clinical trials are eventually approved by the authorities. The acceleration of new developments in the field of medicine, such as cell and gene therapy, tissue-engineering, and regenerative medicine, will emphasise this trend of increasing complexity. The more dynamic and complex R&D environment results in the involvement of many different stakeholders within the research process (research institutions, CROs, startups, small biotechnology companies, and others). More than ever, players in the healthcare industry are forced to work closely together and rely on strong partnerships to retain their market positions.

To fulfil its expectations as a strong partner in the development and introduction of new drugs, Datwyler launched the Starter Pack, a singlesource solution to support parenteral drug development activities. The new combination of providing packaging components with essential services in one offering was created to support the activity of companies dealing with new parenteral drug development. The Starter Pack provides a complete, robust, readyto- use (RTU) packaging system, easy to order and ready to be globally delivered in small quantities.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global healthcare world. Our state-of-the-art solutions for drug packaging and medical devices build on over 100 years of experience. For more information, visit sealing.datwyler.com
spacer
Datwyler
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Reify Health Raises $220 Million to Eliminate Waiting in Clinical Trials

Reify Health today announced a $220 million Series C funding round led by Coatue Management, joined by ICONIQ Growth and Adams Street Partners, as well as existing investors Sierra Ventures and Battery Ventures.
More info >>

White Papers

Clinical Trial-Specific Travel Programs as a Patient Retention Tool

For many patients, participating in a clinical trial is a major endeavor. Depending on the protocol requirements, study visits can be exhausting. There are a number of reasons why a patient may choose to participate in a trial only to drop out. Conversely, there are several approaches to proactively try to prevent this from happening. There are various methods professionals implement for patient retention. This white paper explores patient travel services as one patient retention strategy.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement